IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GRISANTI, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.503
AS - Asia 5.605
EU - Europa 3.905
SA - Sud America 1.063
Continente sconosciuto - Info sul continente non disponibili 327
AF - Africa 145
OC - Oceania 11
Totale 21.559
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.245
SG - Singapore 2.098
CN - Cina 1.469
IT - Italia 905
BR - Brasile 853
HK - Hong Kong 553
DE - Germania 485
UA - Ucraina 452
VN - Vietnam 420
PL - Polonia 419
FI - Finlandia 407
BD - Bangladesh 367
FR - Francia 272
GB - Regno Unito 227
RU - Federazione Russa 227
TR - Turchia 171
CA - Canada 147
IE - Irlanda 136
IN - India 136
AR - Argentina 80
ID - Indonesia 67
SE - Svezia 67
NL - Olanda 63
JP - Giappone 57
CZ - Repubblica Ceca 56
MX - Messico 55
IQ - Iraq 53
ZA - Sudafrica 50
PK - Pakistan 34
AT - Austria 33
EC - Ecuador 32
BE - Belgio 30
ES - Italia 28
UZ - Uzbekistan 23
SA - Arabia Saudita 22
CO - Colombia 21
MA - Marocco 21
AE - Emirati Arabi Uniti 18
CH - Svizzera 18
VE - Venezuela 18
PY - Paraguay 17
LT - Lituania 14
CL - Cile 13
EG - Egitto 13
PH - Filippine 13
AZ - Azerbaigian 12
DZ - Algeria 12
GR - Grecia 12
JM - Giamaica 12
PE - Perù 12
CR - Costa Rica 11
JO - Giordania 11
PT - Portogallo 11
KE - Kenya 10
AU - Australia 9
NP - Nepal 9
IL - Israele 8
LB - Libano 8
NG - Nigeria 8
PA - Panama 8
UY - Uruguay 8
AL - Albania 7
HN - Honduras 7
ET - Etiopia 6
TH - Thailandia 6
TN - Tunisia 6
TW - Taiwan 6
IR - Iran 5
KZ - Kazakistan 5
LY - Libia 5
RS - Serbia 5
BG - Bulgaria 4
CY - Cipro 4
DO - Repubblica Dominicana 4
GY - Guiana 4
KG - Kirghizistan 4
KR - Corea 4
LV - Lettonia 4
MU - Mauritius 4
MY - Malesia 4
OM - Oman 4
RO - Romania 4
BO - Bolivia 3
DK - Danimarca 3
EE - Estonia 3
EU - Europa 3
LK - Sri Lanka 3
MD - Moldavia 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
GT - Guatemala 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TG - Togo 2
Totale 21.212
Salva come PNG Salva come JPEG
Città #
Singapore 1.118
Ashburn 1.001
Fairfield 746
San Jose 703
Hong Kong 542
Woodbridge 532
Warsaw 410
Houston 402
Dallas 354
New York 332
The Dalles 328
Beijing 317
Seattle 315
Jacksonville 313
Los Angeles 307
Cambridge 306
Chandler 301
Chicago 272
Wilmington 266
Helsinki 263
Council Bluffs 196
Princeton 178
Ann Arbor 166
Lauterbourg 152
Ho Chi Minh City 145
Munich 142
Istanbul 135
Columbus 125
Buffalo 122
Salt Lake City 110
Dublin 104
Brescia 103
Moscow 90
Nanjing 87
Milan 85
Santa Clara 83
São Paulo 82
Shanghai 80
Turku 78
Boardman 72
Hanoi 72
Redondo Beach 66
Des Moines 60
San Francisco 60
Secaucus 57
Tampa 53
Elk Grove Village 51
Jakarta 51
Dearborn 50
Orem 46
Rome 46
London 45
Phoenix 44
Brno 42
Lancaster 42
Brooklyn 41
Montreal 39
Changsha 38
Naples 38
San Diego 38
Nanchang 37
Washington 35
Frankfurt am Main 33
Nuremberg 33
Tokyo 33
Dong Ket 32
Atlanta 31
Chennai 31
Poplar 31
Dalmine 30
Rio de Janeiro 30
Toronto 30
Romola 29
Sterling 29
Stockholm 29
Lappeenranta 28
Shenyang 28
Brussels 26
Da Nang 26
Denver 26
Tianjin 26
West Jordan 26
Boston 25
Belo Horizonte 24
Guangzhou 22
Johannesburg 22
Menlo Park 22
Hangzhou 21
Jinan 21
Tashkent 21
Amsterdam 20
Charlotte 20
Haiphong 20
Vienna 20
Bergamo 19
Manchester 19
Ankara 18
Turin 18
Las Vegas 17
Zhengzhou 17
Totale 13.467
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 794
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 383
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 257
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 252
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 252
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 251
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 230
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 226
Immunotherapy failure in adrenocortical cancer: where next? 224
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 222
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 213
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 211
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 210
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 210
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 208
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 202
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 200
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 200
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 200
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 194
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 194
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 191
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 186
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 185
Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors 183
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 183
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 179
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 175
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 174
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 174
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli 171
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 171
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 171
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 168
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 168
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 165
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 163
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 162
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 159
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 157
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 156
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 155
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 155
Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy 153
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 153
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial 152
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases 148
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial 147
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 147
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 146
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 143
Oncological treatment administration at end of life: a retrospective study 142
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 142
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 142
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 141
An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial 141
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 140
Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer. 139
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 137
Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment 135
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 135
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 134
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 133
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 131
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 131
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 131
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 131
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 131
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 130
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 130
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 127
Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma 127
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 126
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 123
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 123
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 122
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 121
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 121
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 121
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 119
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 119
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 118
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 117
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 115
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 114
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 113
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 113
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. 112
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group 111
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 111
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation 109
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 107
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 106
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 106
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 102
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 102
Comparison of the prognostic classification with recursive partitioning analysis (RPA) and general prognostic assessment (GPA) in a retrospective analysis of 430 patients with brain metastases 101
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma 101
Dynamic Susceptibility Contrast MR Imaging inGlioblastomas: Correlation of Whole-TumorHistogram Analysis of the Normalized CerebralBlood Volume and Vascular Permeability withHistopathologic and Molecular Markers of TumorAggressiveness 100
Needs in breast cancer patients (pts) during chemotherapy: Customer satisfaction evaluation 99
Totale 16.255
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.405
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022781 0 82 30 96 22 53 36 56 43 108 64 191
2022/2023823 106 53 42 63 70 191 5 74 119 22 44 34
2023/20241.474 71 41 133 93 104 269 46 79 226 69 49 294
2024/20254.477 50 47 62 557 406 297 276 151 457 288 1.014 872
2025/20268.461 667 1.045 733 955 793 554 1.171 333 555 777 502 376
2026/2027584 376 208 0 0 0 0 0 0 0 0 0 0
Totale 21.559